MoonLake Immunotherapeutics

MLTX

0 Obserwujący

$38.46

-3.23%

-$1.28

Obserwuj

5 Sierpień

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

MLTX Fair Price

$17.08

Overvalued by 40.8%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

MoonLake Immunotherapeutics is a biotechnology company focused on developing immunotherapies for the treatment of autoimmune diseases and cancer. The company utilizes advanced technology that combines biological molecules and monoclonal antibodies for targeted therapy, focusing on specific immune pathways that are critical for the development of various diseases. MoonLake specializes in developing drugs for conditions such as psoriasis, cancer, and other autoimmune disorders, aiming to provide new and effective therapeutic options for patients with these serious diseases.

Feed

There are no posts to show right now.